NRx Pharmaceuticals (NRXP) Institutional Ownership $2.03 -0.24 (-10.57%) Closing price 03/3/2025 04:00 PM EasternExtended Trading$2.04 +0.02 (+0.74%) As of 03/3/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for NRx Pharmaceuticals (NASDAQ:NRXP)CurrentInstitutional OwnershipPercentage4.27%Number ofInstitutional Buyers(last 12 months)6TotalInstitutional Inflows(last 12 months)$907.12KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$1.54M Get NRXP Insider Trade Alerts Want to know when executives and insiders are buying or selling NRx Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NRXP Institutional Buying and Selling by Quarter NRx Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Squarepoint Ops LLC25,299$56K0.0%N/A0.161% 2/17/2025 Millennium Management LLC27,624$61K0.0%N/A0.176% 2/17/2025 Anson Funds Management LP185,660$408K0.0%+30.3%1.183% 2/14/2025 AdvisorShares Investments LLC310,314$683K0.1%+138.5%1.977% 2/14/2025 Sassicaia Capital Advisers LLC15,000$33K0.8%N/A0.096% 11/15/2024 Anson Funds Management LP142,525$241K0.0%N/A1.326% 11/13/2024 Townsquare Capital LLC15,041$25K0.0%N/A0.140% 8/8/2024 AdvisorShares Investments LLC108,085$279K0.0%-82.4%1.010% 8/6/2024 One Wealth Management Investment & Advisory Services LLC15,041$37K0.0%-89.3%0.141% 2/14/2024 AdvisorShares Investments LLC642,632$296K0.1%N/A0.755% Get the Latest News and Ratings for NRXP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NRx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/25/2024 One Wealth Management Investment & Advisory Services LLC140,402$65K0.0%N/A0.165% 11/15/2023 Sabby Management LLC325,000$84K0.1%-53.6%0.398% 5/1/2023 Virtu Financial LLC46,210$30K0.0%N/A0.065% 2/9/2023 HBK Sorce Advisory LLC58,460$65K0.0%N/A0.086% 1/31/2023 AE Wealth Management LLC29,515$33K0.0%N/A0.044% 1/27/2023 Exchange Traded Concepts LLC26,924$30K0.0%+154.0%0.040% 1/18/2023 Exchange Traded Concepts LLC26,924$30K0.0%+154.0%0.040% 11/3/2022 Texas Capital Bank Wealth Management Services Inc.63,290$47K0.0%N/A0.094% 5/18/2022 Ursa Fund Management LLC15,000$37K0.0%N/A0.023% 4/29/2022 United Asset Strategies Inc.18,300$45K0.0%N/A0.027% 2/9/2022 Wolverine Asset Management LLC37,105$177K0.0%-12.8%0.063% 2/8/2022Raymond James Financial Services Advisors Inc.11,567$55K0.0%N/A0.020% 11/15/2021 Penserra Capital Management LLC2,956$27K0.0%N/A0.005% 11/12/2021 Wolverine Asset Management LLC42,568$394K0.0%+118.4%0.079% 11/5/2021 Advisor Group Holdings Inc.42,885$398K0.0%+1,197.6%0.080% 11/2/2021 Cambridge Investment Research Advisors Inc.153,523$1.42M0.0%N/A0.285% 8/16/2021 Owl Creek Asset Management L.P.300,000$3.40M0.2%N/A0.626% 8/16/2021 Ionic Capital Management LLC35,721$415K0.0%N/A0.075% 8/16/2021 Linden Advisors LP364,352$4.23M0.0%N/A0.760% 8/13/2021 Northern Trust Corp130,633$1.52M0.0%N/A0.273% 8/13/2021 Yakira Capital Management Inc.11,923$139K0.0%N/A0.025% 8/13/2021 Geode Capital Management LLC34,475$400K0.0%N/A0.072% 8/13/2021 Vanguard Group Inc.637,416$7.41M0.0%N/A1.330% (Data available from 1/1/2016 forward) NRXP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NRXP shares? During the previous two years, 9 institutional investors and hedge funds held shares of NRx Pharmaceuticals. The most heavily invested institutionals were AdvisorShares Investments LLC ($683K), Anson Funds Management LP ($408K), Sabby Management LLC ($84K), Millennium Management LLC ($61K), Squarepoint Ops LLC ($56K), One Wealth Management Investment & Advisory Services LLC ($37K), and Sassicaia Capital Advisers LLC ($33K).Learn more on NRXP's institutional investors. What percentage of NRx Pharmaceuticals stock is owned by institutional investors? 4.27% of NRx Pharmaceuticals stock is owned by institutional investors. Learn more on NRXP's institutional investor holdings. Which institutional investors have been buying NRx Pharmaceuticals stock? The following institutional investors have purchased NRx Pharmaceuticals stock in the last 24 months: AdvisorShares Investments LLC ($822.86K), Anson Funds Management LP ($185.66K), One Wealth Management Investment & Advisory Services LLC ($140.40K), Virtu Financial LLC ($46.21K), Millennium Management LLC ($27.62K), Squarepoint Ops LLC ($25.30K), and Townsquare Capital LLC ($15.04K). How much institutional buying is happening at NRx Pharmaceuticals? Institutional investors have bought a total of 1,278,097 shares in the last 24 months. This purchase volume represents approximately $39.97M in transactions. Which NRx Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold NRx Pharmaceuticals stock in the last 24 months: AdvisorShares Investments LLC ($506.71K), Sabby Management LLC ($374.73K), and One Wealth Management Investment & Advisory Services LLC ($125.36K). How much institutional selling is happening at NRx Pharmaceuticals? Institutional investors have sold a total of 1,006,800 shares in the last 24 months. This volume of shares sold represents approximately $11.29M in transactions. Related Companies Invivyd Major Shareholders Aclaris Therapeutics Major Shareholders Cidara Therapeutics Major Shareholders Checkpoint Therapeutics Major Shareholders Actuate Therapeutics Major Shareholders Nuvectis Pharma Major Shareholders Puma Biotechnology Major Shareholders Adaptimmune Therapeutics Major Shareholders Windtree Therapeutics Major Shareholders Sutro Biopharma Major Shareholders This page (NASDAQ:NRXP) was last updated on 3/4/2025 by MarketBeat.com Staff From Our PartnersHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredLeaked Trump video exposes his secret stocksTen investments secretly owned by Trump’s biggest backers. Ten investments intrinsically tied to the polici...Porter & Company | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...American Alternative | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NRx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NRx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.